Luo, Zhu
Miao, Jia
Shu, Shiqing
Wang, Ying
Zhu, Xiaohong
Hu, Chao
Shen, Yali
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain
https://doi.org/10.1007/s40261-019-00870-w
Article History
First Online: 2 November 2019
Compliance with Ethical Standards
:
: The study was sponsored and funded by Mundipharma (China) Pharmaceutical Co. Ltd. (Beijing, People’s Republic of China).
: The authors have declared that no financial relationships with any organizations that might have an interest in the submitted work; no other relationships or activities that could influence the submitted work.
: The study protocol was approved by the Independent Ethics Committee of West China Hospital, Sichuan University (Chengdu, China). All procedures in this study were carried out in accordance with the Helsinki declaration.
: Written informed consent was obtained from each subject before screening procedures.